期刊文献+

CD40分子在乳腺癌组织中表达的研究 被引量:1

Study on CD40 molecular expression in breast carcinoma
下载PDF
导出
摘要 目的 探讨乳腺癌组织中CD40分子表达与癌组织浸润转移的关系 ,以及其与ER、PCNA之间的相关性。方法 运用免疫组织化二步法 (Envision法 )对 42例福尔马林固定石蜡包埋的乳腺癌组织进行回顾性研究 ,并且选择 1 5例纤维腺瘤患者作为对照。结果 CD40、ER和PCNA在乳腺癌组织中表达阳性率分别为 35 .7%、54 .8%和 47.6 % ,与纤维腺瘤组相比 ,具显著性差异 (P <0 .0 5或P <0 .0 1 ) ;ER、PCNA与淋巴结转移有关 (P <0 .0 5或P <0 .0 0 1 ) ,CD40与淋巴结转移无相关性 (P >0 .0 5) ;CD40在乳腺癌的表达与ER、PCNA并不存在显著相关性 (P >0 .0 5)。结论 细胞发生恶变后 ,其分子表达常常发生改变 ,从而导致细胞的生物学行为异常。CD40分子在乳腺癌组织中的异常表达可为乳腺癌的诊断。 Objective To explore the relation between CD40 molecular expression and metastasis in human breast carcinoma,and the correlation between expression of CD40,ER and PCNA.Methods Formalin fixed and paraffin embeded tissues from 42 cases of breast carcinoma were studied by Envision immunohistochemical technique,and 15 fibroadenomas as controls.Results The positive rate of CD40,ER and PCNA in 42 samples of human breast carcinoma was 35.7%,54.8% and 47.6%,and there were significant differences compared with that of fibroadenomas(P<0.05 or P<0.01).ER?PCNA in lymph node positive tissues were higher than those in lymph node negative tissues(P<0.05 or P<0.001),and CD40 expression wasn′t correlated with lymph node metastasis(P>0.05).The expression of CD40 wasn′t related to that of ER and PCNA(P>0.05).Conclusion After cells become malignant,its molecular expression often changes,and biological behavior of cells is abnormal.Abnormal expression of CD40 molecule may offer reliable evidence for diagnosis,treatment and prognosis in breast carcinoma.
出处 《中国肿瘤临床与康复》 2002年第4期31-33,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 乳腺癌 免疫组织化学 CD40 ER PCNA breast carcinoma immunohistochemistry CD40 ER,PCNA
  • 相关文献

参考文献1

二级参考文献3

  • 1Li R,Nature,1994年,371卷,534页
  • 2Xiong Y,Nature,1993年,366卷,701页
  • 3Xiong Y,Cell,1992年,71卷,505页

共引文献5

同被引文献9

  • 1李锐,陈卫昌,刘强,柴玉海.胃癌和癌旁组织CD40表达及其生物学意义[J].肿瘤学杂志,2005,11(2):120-122. 被引量:4
  • 2邓敏,施勤,顾永平,谢芳,张学光.CD40、P53在乳腺癌中的表达和生物学意义[J].中国现代医药杂志,2006,8(1):36-38. 被引量:2
  • 3张峻,陈纪林,顾晴,关婷,陈曦.阻断CD40-CD40配体系统对动脉粥样硬化的影响[J].中国动脉硬化杂志,2006,14(2):119-122. 被引量:18
  • 4Hellings PW, Kasran A, Bullens D, et al. IL-10- and IL- 12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling[J]. J Immunol, 2006, 177(8): 5138-5144.
  • 5Yamada M, Shiroko T, Kawaguchi Y, et al. CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I , ICAM-1 and Fas expression and proliferation of human nonsmall cell lung tumors [J]. Int J Cancer, 2001, 92(4):589-599.
  • 6Holub M,Zakeri SM,Lichtenberger C, et al. Heterogeneous expression and regulation of CD40 in human hepatocellular carcinoma[J]. Eur J Gastroenterol Hepatol, 2003, 15(2): 119-126.
  • 7Lo SS, Wu CW, Chi CW, et al. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis[J]. Hepatogastroenterology, 2005, 52 (66): 1902-1904.
  • 8Ottaiano A, De Chiara A, Perrone F, et al. Prognostic value of CD40 in adult soft tissue sarcomas [J]. Clin Cancer Res, 2004, 10(8):2824-2831.
  • 9蒋永芳,龚国忠,赖力英,蒋谊,苏先狮.原发性肝细胞癌组织中CD40的表达及意义[J].中国现代医学杂志,2003,13(13):80-82. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部